Photo by cdc from unsplash
Conventional fractionated radiotherapy (CRT) achieves control of pathological hypercortisolism in 75%‐80% of patients with persistent or recurrent Cushing's disease (CD), over a mean period of 18‐24 months. Medical therapy is… Click to show full abstract
Conventional fractionated radiotherapy (CRT) achieves control of pathological hypercortisolism in 75%‐80% of patients with persistent or recurrent Cushing's disease (CD), over a mean period of 18‐24 months. Medical therapy is recommended as bridge therapy while awaiting RT effect.
Keywords:
cushing disease;
act radioprotective;
agent cushing;
radioprotective agent;
may act;
cabergoline may
Journal Title: Clinical Endocrinology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Endocrinology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!